ID
30172
Beschrijving
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00462332
Link
https://clinicaltrials.gov/show/NCT00462332
Trefwoorden
Versies (1)
- 16-05-18 16-05-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
16 mei 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Leukemia NCT00462332
Eligibility Leukemia NCT00462332
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia NCT00462332
- StudyEvent: Eligibility
C1335499 (UMLS CUI [2])
C3540840 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0700589 (UMLS CUI [1,2])
C0009961 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0311392 (UMLS CUI [3,1])
C0019054 (UMLS CUI [3,2])
C0009450 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0205318 (UMLS CUI [1,4])
C0020517 (UMLS CUI [2,1])
C2916903 (UMLS CUI [2,2])
C0002792 (UMLS CUI [3,1])
C2916903 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C1699668 (UMLS CUI [4,2])
C0002792 (UMLS CUI [5,1])
C1699668 (UMLS CUI [5,2])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C3263723 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C3840291 (UMLS CUI [3,1])
C0439801 (UMLS CUI [3,2])
C0525058 (UMLS CUI [3,3])
C1514463 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0679637 (UMLS CUI [1,2])
C1514457 (UMLS CUI [1,2])